Log in or Sign up for Free to view tailored content for your specialty!
Bone Marrow Transplantation News
Novel approach may eliminate survival disparity in HSCT, greatly expand access
Use of post-transplant cyclophosphamide prophylaxis to prevent graft-versus-host disease could greatly expand access to hematopoietic stem cell transplantation, according to results of a retrospective study.
Novel intervention reduces anxiety, improves quality of life after stem cell transplant
A telephone-administered, positive psychology intervention improved the well-being of patients who underwent hematopoietic stem cell transplantation, according to findings published in Journal of the National Comprehensive Cancer Network.
Experts suggest COVID-19 prevention drug for immunocompromised patients
In new guidance, the Infectious Diseases Society of America suggested that immunocompromised patients take the monoclonal antibody pemivibart as pre-exposure prophylaxis to prevent severe COVID-19.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves Niktimvo for chronic GVHD
The FDA approved axatilimab-csfr for certain patients with chronic graft-versus-host disease.
‘Quite striking’: Donor socioeconomic status may affect stem cell transplant outcomes
The socioeconomic status of cell donors may affect outcomes of people with blood cancer who undergo hematopoietic stem cell transplantation, according to retrospective study results.
BLOG: suPAR as a biomarker among patients undergoing allogeneic HCT
Acute kidney injury is a frequent complication following hematopoietic cell transplantation.
Women can have ‘successful and safe’ pregnancies after allogeneic transplant
Women who undergo allogeneic hematopoietic cell transplantation can get pregnant and have healthy children, according to results of a retrospective study conducted in Germany.
ASH to present honorific awards to ‘visionary’ hematologists
Several hematologists will be honored during this year’s ASH Annual Meeting.
‘Broader and more inclusive design’ needed for novel cancer trials
Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.
New approach ‘redefining what is a suitable donor’ for stem cell transplant
CHICAGO — Interim results from a phase 2 study showed positive survival outcomes for individuals who underwent peripheral blood stem cell transplantation for hematologic malignancies.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read